This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
iot: Archive
QCOM vs. ASTS: Which Wireless Innovator is the Smarter Bet for 2026?
by Supriyo Bose
Qualcomm's steady growth and stronger valuation may give it the edge over AST SpaceMobile in the 2026 wireless showdown.
QCOMNegative Net Change TPositive Net Change VZPositive Net Change ASTSPositive Net Change
artificial-intelligence communications iot mobile semiconductor tech-stocks telecom
ANET vs. IBM: Which Hybrid Cloud Stock is the Better Buy for 2026?
by Supriyo Bose
IBM edges out Arista as the better hybrid cloud pick for 2026, thanks to valuation appeal and multi-cloud momentum.
AMZNNegative Net Change MSFTPositive Net Change IBMPositive Net Change ANETPositive Net Change
artificial-intelligence cloud-computing computers iot software tech-stocks
3 Communication Stocks Set to Benefit From Industry Strength
by Supriyo Bose
The infrastructure upgrade for digital transformation, fiber densification and 5G rollout should help the Zacks Communication - Infrastructure industry thrive. COMM, IHS and BAND are likely to benefit from the continued transition to cloud networks.
IHSPositive Net Change BANDNegative Net Change
cloud-computing communications iot tech-stocks
T Boosts Network Readiness for Winter Storms: Can it Drive Growth?
by Zacks Equity Research
AT&T bolsters its network with snow-ready gear, backup power and rapid-response teams to keep customers connected through winter storms.
TPositive Net Change VZPositive Net Change TMUSPositive Net Change
communications iot mobile tech-stocks
Should You Buy Alpine Income (PINE) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
PINENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CLS Stock Surges 260% in a Year: Can It Sustain This Growth Pace?
by Supriyo Bose
CLS surges 260% in a year, fueled by AI demand, product innovation and a bullish 2025 revenue and earnings outlook.
JBLPositive Net Change FLEXPositive Net Change CLSPositive Net Change
artificial-intelligence electronics iot tech-stocks
The Pennant Group, Inc. (PNTG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PNTGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will IBM's Purported Confluent Buyout Spur the Growth Engine?
by Arijit Sarkar
IBM's reported $11 billion move for Confluent aims to strengthen its real-time data capabilities and expand its cloud-native services footprint.
AMZNNegative Net Change MSFTPositive Net Change IBMPositive Net Change CFLTNegative Net Change
cloud-computing computers iot tech-stocks
ASTS Shares Zoom on Upcoming BlueBird 6 Launch: Worth Buying Now?
by Supriyo Bose
ASTS jumps 18.3% ahead of BlueBird 6 launch as investors eye its next-gen satellite and major carrier deals.
TPositive Net Change VZPositive Net Change AVNWPositive Net Change CMTLNegative Net Change ASTSPositive Net Change
communications iot mobile tech-stocks telecom
Should You Buy Si-Bone (SIBN) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SIBNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines